Mordechai Rosenberg - Aug 20, 2021 Form 4 Insider Report for Ault Global Holdings, Inc. (AULT)

Role
Director
Signature
/s/ Mordechai Rosenberg
Stock symbol
AULT
Transactions as of
Aug 20, 2021
Transactions value $
$0
Form type
4
Date filed
8/24/2021, 07:35 PM
Next filing
Nov 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AULT Common Stock Options Exercise $0 +50K $0.00 50K Aug 20, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AULT Restricted Stock Grant Options Exercise $0 -50K -50% $0.00 50K Aug 20, 2021 Common Stock 50K Direct F2, F3
transaction AULT Restricted Stock Grant Award $0 +50K $0.00 50K Aug 20, 2021 Common Stock 50K Direct F2, F4
transaction AULT Stock Options (Right to Buy) Disposed to Issuer -150K -100% 0 Aug 20, 2021 Common Stock 150K $4.49 Direct F5
transaction AULT Stock Options (Right to Buy) Award +150K 150K Aug 20, 2021 Common Stock 150K $2.55 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting of restricted stock.
F2 Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.001, of Ault Global Holdings, Inc.
F3 On November 2, 2020, Mr. Rosenberg was granted 100,000 restricted shares of the Issuer's Common Stock (the "Restricted Shares"), which vest in two equal installments on each of August 20, 2021, and November 15, 2021. The grant of Restricted Shares was approved at the Issuer's Annual Meeting of Stockholders on August 13, 2021, and authorized by the NYSE American on August 20, 2021.
F4 On January 8, 2021, Mr. Rosenberg was granted 50,000 shares of the Issuer's Common Stock (the "Restricted Shares"), which vest in four installments on each of May 15, 2022, November 15, 2022, May 1, 2023 and November 15, 2023. The grant of Restricted Shares was approved at the Issuer's Annual Meeting of Stockholders on August 13, 2021, and authorized by the NYSE American on August 20, 2021.
F5 On April 26, 2021, the Issuer's Board of Directors approved an option repricing effective August 20, 2021, which resulted in, for purposes of the Exchange Act, the cancellation of these stock options granted to Mr. Rosenberg on January 8, 2021, in exchange for new stock options (the "Options") having a lower exercise price of $2.55 per share. All of the other terms of the Options remained unchanged. The Options were approved at the Issuer's Annual Meeting of Stockholders on August 13, 2021, and authorized by the NYSE American on August 20, 2021.